CX 2026 Registration
CX Executive Board
CX 2026 Programme
CX 2026 – The 48th Charing Cross Symposium
The Charing Cross (CX) Symposium continues to set the standard in vascular and endovascular education, shaping the future of practice worldwide. CX 2026 marked the final chapter of our current three-year cycle, designed to spark debate on the biggest controversies in the field. Our distinguished faculty of global experts critically examined the evidence, exchanged perspectives, and worked towards building consensus on the issues that matter most.
Consensus was the defining theme for CX 2026. We welcomed an international community of specialists, educators, and innovators to tackle the pressing challenges in vascular and endovascular medicine—challenges that directly impact patient outcomes and clinical decision-making.
In 2024, CX found a new home at ExCeL London, unlocking fresh opportunities for immersive, hands-on learning. The expanded workshop programme has gone from strength to strength, offering delegates practical skills alongside groundbreaking evidence and innovation. In 2026, we returned once again to London’s premier conference and exhibition venue to deliver an agenda packed with cutting-edge science, expert debate, and future-shaping education.
Stay connected—sign up for the CX Newsletter and be the first to hear the latest updates.
CX Co-Chairs
Latest CX news
CX 2023: Reaching Aortic Consensus with a World-Class Faculty!
This year we expect over 2,500 in-person and 1,000 virtual participating vascular specialists to join us. In previous years we have hosted over 6,000 registrants virtually from over 120 countries due to the COVID-19 pandemic and are [...]
CX 2023: Reaching Venous and Lymphatic Consensus with a World-Class Faculty
CX 2023 is seeking to reach venous and lymphatic consensus on topics related to the superficial, deep and pelvic veins as well as venous ulcers and lymphatics. Reaching consensus this year will [...]
Edited case in the spotlight: Long-term clinical and patient focused outcomes for no-hope CLTI patients, Miguel Montero-Baker (Houston, United States)
Dr Miguel Montero-Baker (Houston, United States) stresses that the current disease state of peripheral arterial disease (PAD) is leading to more complex below the ankle calcification patterns, specifically in renal failure patients. Within [...]





